- Home
- PHGE vs ERNA Comparison
PHGE vs ERNA Comparison
Compare PHGE & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- ERNA
- Stock Information
- Founded
- PHGE 2015
- ERNA 2018
- Country
- PHGE Israel
- ERNA United States
- Employees
- PHGE N/A
- ERNA N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- PHGE Health Care
- ERNA Health Care
- Exchange
- PHGE Nasdaq
- ERNA Nasdaq
- Market Cap
- PHGE 13.3M
- ERNA 14.5M
- IPO Year
- PHGE N/A
- ERNA N/A
- Fundamental
- Price
- PHGE $0.59
- ERNA $0.19
- Analyst Decision
- PHGE Strong Buy
- ERNA
- Analyst Count
- PHGE 2
- ERNA 0
- Target Price
- PHGE $23.00
- ERNA N/A
- AVG Volume (30 Days)
- PHGE 200.7K
- ERNA 213.9K
- Earning Date
- PHGE 05-19-2025
- ERNA 05-13-2025
- Dividend Yield
- PHGE N/A
- ERNA N/A
- EPS Growth
- PHGE N/A
- ERNA N/A
- EPS
- PHGE N/A
- ERNA N/A
- Revenue
- PHGE N/A
- ERNA $582,000.00
- Revenue This Year
- PHGE N/A
- ERNA N/A
- Revenue Next Year
- PHGE N/A
- ERNA N/A
- P/E Ratio
- PHGE N/A
- ERNA N/A
- Revenue Growth
- PHGE N/A
- ERNA 755.88
- 52 Week Low
- PHGE $0.48
- ERNA $0.15
- 52 Week High
- PHGE $4.99
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- PHGE 51.14
- ERNA 44.20
- Support Level
- PHGE $0.52
- ERNA $0.17
- Resistance Level
- PHGE $0.57
- ERNA $0.21
- Average True Range (ATR)
- PHGE 0.05
- ERNA 0.02
- MACD
- PHGE 0.01
- ERNA 0.00
- Stochastic Oscillator
- PHGE 62.83
- ERNA 73.00
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
About ERNA Eterna Therapeutics Inc.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.